Status:
COMPLETED
Possible Links Between Inflammation and Lipid Metabolism
Lead Sponsor:
Barmherzige Brüder Linz
Conditions:
Sepsis
Inflammation
Eligibility:
MALE
18-40 years
Phase:
NA
Brief Summary
It has been recognized lately that sepsis and inflammation has an important impact on lipid metabolism and that the extent of hypocholesterolemia may even be a marker of severity of illness. However, ...
Detailed Description
Sepsis is a severe clinical syndrome with still limited means of therapy and often poor prognosis. It has been recognized lately that sepsis and inflammation has an important impact on lipid metabolis...
Eligibility Criteria
Inclusion
- Men aged 18 to 40 years
- Written informed consent
- No disease history
- non-smoker
- BNP level within the normal range
- Normal renal function (serum creatinine of 1.3 mg/dL and/or creatinine clearance greater than 80ml/min)
Exclusion
- Systolic blood pressure \< 90 mmHg
- Subjects on any medication
- History of anaphylaxis
- Probands who suffer from infectious disease
Key Trial Info
Start Date :
December 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2018
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03392701
Start Date
December 20 2017
End Date
September 30 2018
Last Update
October 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barmherzige Brüder Linz - Innere Medizin
Linz, Austria, 4021